GlassScriptPhysician profile
Desiree Rodriguez
NPI 1922673730
$2,302.67
in general payments reported to CMS, 2019-2025
20 companies · $561 in 2025
The $561 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.79 · 2022: $845 · 2023: $338 · 2024: $484 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,298 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,297.73 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $633.54 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $342.27 | 2021-2024 | Xarelto, Spravato |
| Astrazeneca Pharmaceuticals LP | $270.40 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $178.85 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $149.28 | 2021-2024 | Mounjaro, Zepbound |
| Cvrx, INC. | $126.01 | 2025 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $117.01 | 2022-2025 | |
| Merz Pharmaceuticals, LLC | $85.00 | 2024 | |
| Amgen INC. | $64.81 | 2021-2025 | Otezla, Repatha, Otezla |
| Almatica Pharma LLC | $47.75 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $45.41 | 2022 | |
| Esperion Therapeutics, INC. | $44.07 | 2025 | Nexletol |
| Pfizer INC. | $42.22 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.98 | 2022 | |
| Alnylam Pharmaceuticals INC. | $25.66 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.39 | 2024 | Freestyle Libre 3 |
| Collegium Pharmaceutical, INC. | $21.18 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.27 | 2025 | Caplyta |
| Exact Sciences Corporation | $15.05 | 2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $14.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desiree Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.